For following the competition: what moved in each program, several studies read as one move.
- Anti-EGFR/Anti-HER3 Bispecific Antibody-drug Conjugate AVZO-1418
- becotatug
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Nasopharyngeal Neoplasms to watchlistEvery Monday by email · turn it off any timePro · free during the beta